These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5612503)

  • 1. [Secondary diuresis following intravenous administration of phenylalanine-2-lysine-8-vasopressin in patients with liver cirrhosis].
    Gómez Mont F; Ramírez C; Perches A; Gómez Peralta L; Nava Lara L
    Gac Med Mex; 1967 Feb; 97(2):244-58. PubMed ID: 5612503
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dose-response relation of the antidiuretic and vasopressor activities of 4-asparagine-8-lysine-vasopressin.
    Pliska V; Krejcí I
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):289-97. PubMed ID: 5926871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ethacrynic acid on diuresis, salidiuresis and electrolyte concentration of the plasma in liver cirrhosis patients with ascites].
    Bardi A; Merino I; Generini G; Rendic Y; Plaza de los Reyes M
    Rev Med Chil; 1967 Jun; 95(6):309-13. PubMed ID: 5614513
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antidiuretic and pressor effects of arginine-8-vasopressin, lysine-8-vasopressin, phenylalanine-2-lysine-8-vasopressin in man].
    GUHL U
    Schweiz Med Wochenschr; 1961 Jul; 91():798-804. PubMed ID: 13709554
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of the drug M.K. 870 on the diuresis, salidiuresis and plasma electrolyte concentration in liver cirrhosis patients with ascites].
    Merino I; Bardi A; Generini G; Rendic Y; Plaza de los Reyes M
    Rev Med Chil; 1967 Jun; 95(6):295-9. PubMed ID: 5614510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of furosemide on diuresis and salt diuresis, blood electrolytes concentrations in various aspects of renal function in liver cirrhotic patients with ascites].
    Bardi A; Merino I; Doerr E; Rendic Y; Generini G; Plaza de los Reyes M
    Rev Med Chil; 1968 Mar; 96(3):142-4. PubMed ID: 5732745
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative potency of arginine-8-vasopressin and lysine-8-vasopressin in humans.
    Miller L; Fisch L; Kleeman CR
    J Lab Clin Med; 1967 Feb; 69(2):270-91. PubMed ID: 6016625
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strength and speed of action of intravenous furosemide in ascitogenic liver cirrhosis in a 20 mg. dose. Preliminary findings].
    Alonso HO; Gaspary F; Turiella RG; Tvrde P; Nicastro F
    Prensa Med Argent; 1967 Sep; 54(27):1373-4. PubMed ID: 5619887
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the neuro-adrenocortical responses to intravenous and subcutaneous administration of lysine-8-vasopressin].
    Hoffman C; Argüelles AE; Poggi UL
    Rev Argent Endocrinol Metab; 1970 Mar; 16(1):1-6. PubMed ID: 5522629
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
    Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of mice to (8-arginine)- and (8-lysine)-vasopressins as antidiuretic hormones.
    Stewart AD
    J Endocrinol; 1973 Oct; 59(1):195-6. PubMed ID: 4748523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous administration of synthetic lysine-8-vasopressin and oxytocin. Effects on blood levels of growth hormone, follicle-stimulating hormone and insulin].
    Kleinknecht D; Rosselin G; Tchobroutsky G; Dolais J
    Presse Med (1893); 1969 May; 77(23):856-8. PubMed ID: 5806688
    [No Abstract]   [Full Text] [Related]  

  • 15. The bioassay of vasopressin through its antidiuretic effect.
    Guzek JW; Leśnik H
    Endokrinologie; 1968; 53(3):201-16. PubMed ID: 5713381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intensive studies with vasopressin lysine].
    Garrido Carmona E
    Rev Asoc Mex Enferm; 1966; 13(1):9-10. PubMed ID: 5179829
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ethacrynic acid on diuresis, electrolyte excretion, and renal function in cases of liver cirrhosis].
    Koçak N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1968; 34(8):502-10. PubMed ID: 5732894
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of lysine 8 -vasopressin on callus formation. I. Morphobiochemical study].
    Conti G; Cappelli-Gotzos B; Spreca A; Musy JP; Gotzos V; Modis L
    Acta Anat (Basel); 1971; 79(2):204-16. PubMed ID: 4107117
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aquaretic agents].
    Jiménez W
    Nefrologia; 2002; 22 Suppl 5():52-5. PubMed ID: 12107918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of antidiuretic activity in the urine following intravenous injection of vasopressin in ethanol anesthetized rats].
    Bödeker J; Schreiber G
    Pflugers Arch; 1971; 325(4):347-58. PubMed ID: 5103986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.